Table 3.
Indication | n (%) |
1 Chronic, stable, irritable bowel syndrome or chronic abdominal pain | 117 (15.9) |
2 Routine follow-up of inflammatory bowel disease | 15 (2.0) |
3 Acute diarrhea | 7 (1.0) |
4 Metastatic adenocarcinoma of unknown primary site in the absence of colonic signs or symptoms when it will not influence management | 6 (0.8) |
5 Upper GI bleeding or melena with a demonstrated upper gastrointestinal source | 4 (0.5) |
1According to 2000 American Society for Gastrointestinal Endoscopy (ASGE) guidelines on appropriate use of gastrointestinal endoscopy[9].